Hrozanova, Maria
Meisingset, Ingebrigt
Kallestad, Håvard
Pallesen, Ståle
Nordstoga, Anne Lovise
Skarpsno, Eivind Schjelderup
Funding for this research was provided by:
EkstraStiftelsen Helse og Rehabilitering (2022/FO387017)
NTNU Norwegian University of Science and Technology
Article History
Received: 9 January 2023
Accepted: 23 February 2023
First Online: 2 March 2023
Declarations
:
: The study protocol was approved by the Regional Committee for Medical and Health Research ethics in Mid-Norway (ID 465241). Protocol amendments will be communicated by updating the information provided on the trial registry website (ref. ISRCTN16185698). Participant informed consent will be obtained digitally using the eForsk platform. This RCT protocol follows the Standard Protocol Items for Randomized Trials (SPIRIT) statement guidelines [] and all methods were carried out with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.